Letter: interpretation of the BESST trial in the context of baseline antidepressant and neuromodulator use

Brent Hiramoto^{1

2}, Walter W Chan^{1

2}

Affiliations

¹ Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
² Harvard Medical School, Boston, Massachusetts, USA.

Comment

Brent Hiramoto et al. Aliment Pharmacol Ther. 2024 Jan.

. 2024 Jan;59(2):291-292.

doi: 10.1111/apt.17800.

Brent Hiramoto^{1

2}, Walter W Chan^{1

2}

¹ Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
² Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Comment in

Letter: interpretation of the BESST trial in the context of baseline antidepressant and neuromodulator use-Authors' reply.
Parkman HP; NIH Gastroparesis Clinical Research Consortium. Parkman HP, et al. Aliment Pharmacol Ther. 2024 Jan;59(2):293-294. doi: 10.1111/apt.17838. Aliment Pharmacol Ther. 2024. PMID: 38153284 No abstract available.

Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST).
Parkman HP, Yates KP, Sarosiek I, Bulat RS, Abell TL, Koch KL, Kuo B, Grover M, Farrugia G, Silver P, Abdullah A, Maurer AH, Malik Z, Miriel LA, Tonascia J, Hamilton F, Pasricha PJ, McCallum RW; NIDDK Gastroparesis Clinical Research Consortium. Parkman HP, et al. Aliment Pharmacol Ther. 2023 Jun;57(11):1272-1289. doi: 10.1111/apt.17479. Epub 2023 Apr 13. Aliment Pharmacol Ther. 2023. PMID: 37052334 Free PMC article. Clinical Trial.

1. Camilleri M, Kuo B, Nguyen L, et al. ACG Clinical Guideline: Gastroparesis. Am J Gastroenterol. Aug 01 2022;117(8):1197–1220. doi:10.14309/ajg.0000000000001874 - DOI - PMC - PubMed
1. Pasricha PJ, Grover M, Yates KP, et al. Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features. Gastroenterology. May 2021;160(6):2006–2017. doi:10.1053/j.gastro.2021.01.230 - DOI - PMC - PubMed
1. Parkman HP, Yates KP, Sarosiek I, et al. Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST). Aliment Pharmacol Ther. Jun 2023;57(11):1272–1289. doi:10.1111/apt.17479 - DOI - PMC - PubMed
1. Tack J, Janssen P, Masaoka T, Farré R, Van Oudenhove L. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol. Nov 2012;10(11):1239–45. doi:10.1016/j.cgh.2012.06.036 - DOI - PubMed